Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KER-065 by Keros Therapeutics for Obesity: Likelihood of Approval
KER-065 is under clinical development by Keros Therapeutics and currently in Phase I for Obesity. According to GlobalData, Phase I...
Data Insights
KER-065 by Keros Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
KER-065 is under clinical development by Keros Therapeutics and currently in Phase I for Duchenne Muscular Dystrophy. According to GlobalData,...